**Core Concept**
The question pertains to the selection of a topical beta blocker for the treatment of glaucoma or ocular hypertension. The ideal drug should have properties that allow for effective reduction of intraocular pressure (IOP) with minimal systemic side effects.

**Why the Correct Answer is Right**
Topical beta blockers work by reducing the production of aqueous humor in the eye, thereby decreasing IOP. The desired properties of a topical beta blocker include selective beta-1 adrenergic receptor blockade, high lipophilicity for prolonged action, and minimal penetration into the systemic circulation to avoid systemic side effects.

**Why Each Wrong Option is Incorrect**
**Option A:** While high lipophilicity is desirable for prolonged action, it is not the only property required for a topical beta blocker.
**Option B:** Minimal penetration into the systemic circulation is a desirable property to avoid systemic side effects, but it is not the only exception.
**Option C:** Selective beta-1 adrenergic receptor blockade is a key property of effective topical beta blockers, so this option is incorrect.

**Clinical Pearl / High-Yield Fact**
When choosing a topical beta blocker, it is essential to consider the patient's systemic health and potential interactions with other medications. For example, systemic beta blockers can exacerbate asthma or heart failure.

**Correct Answer: C. Selective beta-1 adrenergic receptor blockade is a key property of effective topical beta blockers, so this option is incorrect.**